期刊文献+

急性髓系白血病合并自身免疫性溶血性贫血二例 被引量:1

原文传递
导出
摘要 目的在临床诊断急性髓系白血病(AML)且需输血治疗的患者中行抗人球蛋白试验(Coombs试验),筛查AML合并自身免疫性溶血性贫血(AIHA)病例,保障输血安全。方法输血前抽取EDTA抗凝静脉血3ml送检,且同时检测直接Coombs试验和间接Coombs试验。结果在AML需输血治疗的患者中发现2例患者直接Coombs试验阳性。结论AML合并AIHA病例临床少见,但为提高临床医疗安全,Coombs试验筛查是必要的。
出处 《白血病.淋巴瘤》 CAS 2011年第2期119-120,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献10

  • 1Solal-Celigny P, Vazeux R, Vroclans M, et al. Positive eoombs test in acute leukemia. Br J Haematol, 1984, 57: 563-569.
  • 2张凤奎,于阳,张莉,井丽萍,王迎,孙明媛,薛峰,李刚,李洋,储榆林.脾边缘区淋巴瘤伴自身免疫性溶血性贫血1例并文献复习[J].白血病.淋巴瘤,2004,13(2):71-74. 被引量:5
  • 3马健 王晓虹 陈丽贞 等.自身免疫性溶血性贫血伴肠道T细胞淋巴瘤一例[J].中华消化杂志,2000,:20-20.
  • 4Sokol R J, Hewitt S, Booker DJ. Erythrocyte autoantibodies, autoimmune hemolysis, and myelodysplastic syndromes. J Clin Pathol, 1989, 42: 1088-1091.
  • 5Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma, 1997, 24: 483-489.
  • 6Lin JT, Wang WS, Yen CC, et al. Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil. Ann Hematol, 2002, 82: 723- 726.
  • 7BoccardiV, Papa G, A ntoneUi S, et al. Auto immune hemolytic anemia followed by myelomonocytic leukemia. Haematologica, 1977, 62: 88- 94.
  • 8Tamura H, Ogata K, Yokose N, et al. Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemia. Ann Hematol, 1996, 72: 45-47.
  • 9Deutsch M, Dourakis SP, Papanikolopoulos K, et al. Autoimmune hemolytic anemia in a patient with acute myelocytic leukemia. Am J Hematol, 2003, 74: 147.
  • 10丁烨,陆化,沈文怡,费小明,刘增艳,张建富,李建勇.急性髓细胞白血病并发自身免疫性溶血性贫血1例报告并文献复习[J].中国误诊学杂志,2008,8(4):981-982. 被引量:1

二级参考文献34

  • 1Franco V, Florena A M, Iannitto E. Splenic marginal zone lymphoma [J]. Blood,2003,101:2464-2472.
  • 2ThieblemontC, FelmanP, BergerF, et al. Treatment of splenic marginal zone B-cell lymphoma:an analysis of 81 patients [J]. Clin Lymphoma,2002,3:41-47.
  • 3Catovsky D, Matures E. Splenic lymphoma with circulating villous lymphocytes/splenic marginalzone lymphoma [J]. Semin Hematol,1999,36:148-154.
  • 4BowenAL, MatutesE, CatovskyD. Spleniclymphomawithvillous lympbocytes[J]. Haematologica, 1999,84(supp110):90-92.
  • 5Franco V, Florena A M, Campesi G. Intrasinusoidal bone marrow infiltration:a possible hallmark of splenic lymphoma [J]. Histopatbol,1996,29:571 - 575.
  • 6Labouyrie E, Marit G, Vial J, et al. Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes:a helpful immunohistologic feature[J]. Mod Pathol, 1997,10:1015 - 1020.
  • 7Kent S A, Variakoijs D, Peterson L C. Comparative study of marginal zone lymphoma involving bone marrow[J]. Am J Clin Pathol,2002,117:698 -708.
  • 8Troussard X, Valensi F, Duchayne E, et al. Splenic lymphoma with villous lymphocytes:clinical presentation, biology and prognostic factors in a series of 100 patients[J]. Br J Haematol, 1996,93:731 -736.
  • 9Bolam S, Orchard J, Oscier D. Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes[J]. Br J Haematol, 1997,99:158-161.
  • 10LefrereF, HermineO, BelangerC, etal. Fludarabine:aneffective treatment in patients with splenic lymphoma with villous lymphocytes [J]. Leukemia,2000,14:573-575.

共引文献4

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部